These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision. Scarpa F, Sabattini S, Marconato L, Capitani O, Morini M, Bettini G. J Am Vet Med Assoc; 2012 May 15; 240(10):1181-7. PubMed ID: 22559107 [Abstract] [Full Text] [Related]
6. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs. Stanclift RM, Gilson SD. J Am Vet Med Assoc; 2008 Jan 01; 232(1):53-62. PubMed ID: 18167109 [Abstract] [Full Text] [Related]
7. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. Kiupel M, Webster JD, Miller RA, Kaneene JB. J Vet Med A Physiol Pathol Clin Med; 2005 Aug 01; 52(6):280-6. PubMed ID: 16050909 [Abstract] [Full Text] [Related]
8. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival. Krick EL, Billings AP, Shofer FS, Watanabe S, Sorenmo KU. Vet Comp Oncol; 2009 Jun 01; 7(2):130-8. PubMed ID: 19453367 [Abstract] [Full Text] [Related]
9. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. Fulcher RP, Ludwig LL, Bergman PJ, Newman SJ, Simpson AM, Patnaik AK. J Am Vet Med Assoc; 2006 Jan 15; 228(2):210-5. PubMed ID: 16426187 [Abstract] [Full Text] [Related]
16. The tyrosine kinase inhibitor imatinib [STI571] induces regression of xenografted canine mast cell tumors in SCID mice. Kobie K, Kawabata M, Hioki K, Tanaka A, Matsuda H, Mori T, Maruo K. Res Vet Sci; 2007 Apr 15; 82(2):239-41. PubMed ID: 16919303 [Abstract] [Full Text] [Related]
17. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours. Rassnick KM, Bailey DB, Russell DS, Flory AB, Kiselow MA, Intile JL, Malone EK, Balkman CE, Barnard SM. Vet Comp Oncol; 2010 Jun 15; 8(2):138-52. PubMed ID: 20579327 [Abstract] [Full Text] [Related]
18. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V. Vet Pathol; 2004 Jul 15; 41(4):371-7. PubMed ID: 15232137 [Abstract] [Full Text] [Related]
19. Lymph node histology for the assessment of residual neoplastic disease in canine mast cell tumours: does the presence of metachromatic granules always identify mast cells? Ressel L, Finotello R. Vet Comp Oncol; 2017 Dec 15; 15(4):1119-1121. PubMed ID: 27714908 [No Abstract] [Full Text] [Related]